HIGHLIGHTS
- who: G. Samuel from the Medicine, University of Oxford, Oxford , BN, UK have published the article: Exploring how biobanks communicate the possibility of commercial access and its associated benefits and risks in participant documents, in the Journal: (JOURNAL)
- what: The project aims to observe what happens to participants over the next few decades so that future generations can benefit. The Universities and funders involved in this project have a financial interest in using the results to develop new treatments and that this may involve commercial companies (e_g drug companies). This separation often amounted to a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.